Glucagon-like peptide-1 (GLP-1) diminishes neuronal degeneration and death caused by NGF deprivation by suppressing Bim induction

被引:72
作者
Biswas, Subhas C. [1 ,2 ]
Buteau, Jean [3 ,4 ]
Greene, Lloyd A. [1 ,2 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Pathol, Ctr Neurobiol & Behav, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Taub Ctr Alzheimers Dis Res, New York, NY 10032 USA
[3] Univ Laval, Dept Anat & Physiol, Quebec City, PQ G1V 4G5, Canada
[4] Ctr Rech Hop, Quebec City, PQ G1V 4G5, Canada
关键词
neuronal apoptosis; GLP-1; Bim; NGF;
D O I
10.1007/s11064-008-9646-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Glucagon-like peptide-1 (GLP-1) is a glucoincretin hormone most intensively studied for its actions on insulin secreting beta-cells. GLP-1 and its receptor are also found in brain and accumulating evidence indicates that GLP-1 has neuroprotective actions. Here, we investigated whether GLP-1 protects neuronal cells from death evoked by nerve growth factor (NGF) withdrawal. Compromised trophic factor signaling may underlie neurodegenerative diseases ranging from Alzheimer disease to diabetic neuropathies. We report that GLP-1 provides sustained protection of cultured neuronal PC12 cells and sympathetic neurons from degeneration and death caused by NGF deprivation. Past work shows that NGF deprivation induces the pro-apoptotic protein Bim which contributes to neuron death. Here, we find that GLP-1 suppresses Bim induction promoted by NGF deprivation. Thus, GLP-1 may protect neurons, at least in part, by suppressing Bim induction. Our findings support the idea that drugs that mimic or elevate GLP-1 represent potential therapeutics for neurodegenerative diseases.
引用
收藏
页码:1845 / 1851
页数:7
相关论文
共 48 条
[1]
Bim is a direct target of a neuronal E2F-dependent apoptotic pathway [J].
Biswas, SC ;
Liu, DX ;
Greene, LA .
JOURNAL OF NEUROSCIENCE, 2005, 25 (37) :8349-8358
[2]
Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation [J].
Biswas, SC ;
Greene, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (51) :49511-49516
[3]
Bim is elevated in Alzheimer's disease neurons and is required for β-amyloid-induced neuronal apoptosis [J].
Biswas, Subhas C. ;
Shi, Yijie ;
Vonsattel, Jean-Paul G. ;
Leung, Conrad L. ;
Troy, Carol M. ;
Greene, Lloyd A. .
JOURNAL OF NEUROSCIENCE, 2007, 27 (04) :893-900
[4]
Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells [J].
Buteau, J ;
Roduit, R ;
Susini, S ;
Prentki, M .
DIABETOLOGIA, 1999, 42 (07) :856-864
[5]
Transcription factor Fox01 mediates glucagon-like peptide-1 effects on pancreatic β-cell mass [J].
Buteau, J ;
Spatz, ML ;
Accill, D .
DIABETES, 2006, 55 (05) :1190-1196
[6]
Glucagon-like peptide-1 prevents beta cell glucolipotoxicity [J].
Buteau, J ;
El-Assaad, W ;
Rhodes, CJ ;
Rosenberg, L ;
Joly, E ;
Prentki, M .
DIABETOLOGIA, 2004, 47 (05) :806-815
[7]
Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor [J].
Buteau, J ;
Foisy, S ;
Joly, E ;
Prentki, M .
DIABETES, 2003, 52 (01) :124-132
[8]
Protein kinase Cζ activation mediates glucagon-like peptide-1-induced pancreatic β-cell proliferation [J].
Buteau, J ;
Foisy, S ;
Rhodes, CJ ;
Carpenter, L ;
Biden, TJ ;
Prentki, M .
DIABETES, 2001, 50 (10) :2237-2243
[9]
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [J].
Drucker, Daniel J. ;
Nauck, Michael A. .
LANCET, 2006, 368 (9548) :1696-1705
[10]
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection [J].
During, MJ ;
Cao, L ;
Zuzga, DS ;
Francis, JS ;
Fitzsimons, HL ;
Jiao, XY ;
Bland, RJ ;
Klugmann, M ;
Banks, WA ;
Drucker, DJ ;
Haile, CN .
NATURE MEDICINE, 2003, 9 (09) :1173-1179